As of 2024-12-12, the Intrinsic Value of Pharmadrug Inc (PHRX.CN) is
-0.62 CAD. This PHRX.CN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.02 CAD, the upside of Pharmadrug Inc is
-4,222.80%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-0.62 CAD
Intrinsic Value
PHRX.CN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-0.62 - -0.62 |
-0.62 |
-4,222.80% |
| DDM - Stable |
(2.33) - (29.86) |
(16.10) |
-107414.1% |
| DDM - Multi |
(2.41) - (23.62) |
(4.35) |
-29105.6% |
PHRX.CN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1.60 |
| Beta |
0.01 |
| Outstanding shares (mil) |
106.73 |
| Enterprise Value (mil) |
2.87 |
| Market risk premium |
5.10% |
| Cost of Equity |
5.54% |
| Cost of Debt |
5.00% |
| WACC |
5.09% |